Last updated: 2026-10-12 15:11:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
GE HealthCare Technologies Inc. (GEHC) operates in the X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $67,59, with a market capitalisation of $29,69B and a P/E ratio of 14,96. Over the past 52 weeks, its price has ranged from $58,75 to $89,77. This page covers its latest market performance, valuation, price trends and company information.
$29,69B | |
$66,02 | |
$94,80 | |
$53,50 | |
$65,74 | |
756,51K | |
4,11M | |
14,96 | |
$89,77 | |
$58,75 | |
0,22% | |
-- |
GE HealthCare Technologies Inc. (GEHC) is currently trading at $67,59 as of 2026-10-12 14:54:46, up 2,81% ($1,85) from the previous close of $65,74
During today's regular trading session, GEHC has traded between $53,50 and $94,80, with a trading volume of 756,51K shares. The current price is near the lower end of today's range.
Over the past seven days, GE HealthCare Technologies Inc. (GEHC) moved from $63,98 to $67,59, representing a gain of 5,64% ($3,61).
The stock traded between $63,32 and $67,59 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 3,75 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 28,5%
GEHC is currently trading at $67,59, placing it 28,5% of the way from its 52-week low of $58,75 to its 52-week high of $89,77. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
| Industry | X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS |
| Employees | 54000 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of GE HealthCare Technologies Inc. (GEHC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.